SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+20.31%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$754M
AUM Growth
+$754M
(+25%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
48.98%
Holding
104
New
23
Increased
22
Reduced
27
Closed
20
Top Buys
| 1 |
Sanofi
SNY
|
$22.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$21.3M |
| 3 |
Novartis
NVS
|
$18.9M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$11.4M |
| 5 |
Viatris
VTRS
|
$11.3M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
$35.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$24.8M |
| 3 |
Sarepta Therapeutics
SRPT
|
$13.9M |
| 4 |
Gilead Sciences
GILD
|
$13M |
| 5 |
Bristol-Myers Squibb
BMY
|
$12.5M |
Sector Composition
| 1 | Healthcare | 84.32% |
| 2 | Technology | 10.06% |
| 3 | Industrials | 1.58% |
| 4 | Consumer Discretionary | 1.5% |
| 5 | Communication Services | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Krystal Biotech
KRYS
$4.34B
| $4.78M | 0.39% |
86,280
-31,345
| -27% | -$1.74M |
|
|
PRNB
52
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $4.74M | 0.39% |
+86,500
| New | +$4.74M |
|
53
Viking Therapeutics
VKTX
$3B
| $4.73M | 0.39% |
+590,000
| New | +$4.73M |
|
54
Neurogene
NGNE
$280M
| $4.68M | 0.39% |
+379,998
| New | +$4.68M |
|
55
Travere Therapeutics
TVTX
$1.72B
| $4.51M | 0.37% |
317,381
-12,822
| -4% | -$182K |
|
|
FSCT
56
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $4.49M | 0.37% |
137,021
-36,675
| -21% | -$1.2M |
|
57
Burlington
BURL
$18.4B
| $4.45M | 0.37% |
19,500
| – | – |
|
58
Protagonist Therapeutics
PTGX
$3.6B
| $4.44M | 0.37% |
+630,000
| New | +$4.44M |
|
59
Kornit Digital
KRNT
$643M
| $3.48M | 0.29% |
101,759
-29,829
| -23% | -$1.02M |
|
60
Nova
NVMI
$7.06B
| $3.46M | 0.29% |
91,466
+39,517
| +76% | +$1.49M |
|
61
Wabtec
WAB
$32.6B
| $3.11M | 0.26% |
40,000
| – | – |
|
62
Cytokinetics
CYTK
$5.88B
| $2.85M | 0.24% |
+268,747
| New | +$2.85M |
|
63
argenx
ARGX
$43.9B
| $2.66M | 0.22% |
16,581
-22,000
| -57% | -$3.53M |
|
64
KalVista Pharmaceuticals
KALV
$732M
| $2.63M | 0.22% |
+147,700
| New | +$2.63M |
|
65
Teva Pharmaceuticals
TEVA
$21.5B
| $2.55M | 0.21% |
+260,352
| New | +$2.55M |
|
|
ALNA
66
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $2.51M | 0.21% |
917,800
+243,919
| +36% | +$666K |
|
|
IMVTU
67
DELISTED
Immunovant, Inc. Units
IMVTU
| $2.49M | 0.21% |
+100,000
| New | +$2.49M |
|
68
Abeona Therapeutics
ABEO
$356M
| $2.36M | 0.19% |
+720,472
| New | +$2.36M |
|
|
ARYAU
69
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $2.3M | 0.19% |
200,000
| – | – |
|
70
ADMA Biologics
ADMA
$4.07B
| $2.16M | 0.18% |
+540,000
| New | +$2.16M |
|
|
SIOX
71
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.04M | 0.17% |
398,541
-270,000
| -40% | -$1.38M |
|
72
Evolus
EOLS
$480M
| $1.83M | 0.15% |
+150,000
| New | +$1.83M |
|
73
Assembly Biosciences
ASMB
$182M
| $1.81M | 0.15% |
88,248
-31,752
| -26% | -$650K |
|
74
InflaRx
IFRX
$117M
| $1.31M | 0.11% |
+330,000
| New | +$1.31M |
|
|
CNCE
75
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.29M | 0.11% |
140,000
| – | – |
|